EUVIMEDEUVIMED entdecken
Crossref

Clinical impact of Academic Research Consortium for High Bleeding-Risk scores on clinical outcomes in patients with stable coronary artery disease undergoing percutaneous coronary intervention

Hirokazu Shimono, Akihiro Tokushige, Daisuke Kanda, Ayaka Ohno, Ryo Arikawa, Hideto Chaen, Hideki Okui, Naoya Oketani, Mitsuru Ohishi

Heart and Vessels · 2024

DOI: 10.1007/s00380-024-02428-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart and Vessels, 2024. Verfasst von Hirokazu Shimono und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Kagoshima City Hospital, Kagoshima, Japan. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Coronary Artery Disease, Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High bleeding risk (HBR), as defined by the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria, has been recently reported to be associated with an increased risk of major bleeding events and cardiovascular events. We investigated the association between the ARC-HBR score and clinical outcomes in patients with stable coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI). We assessed 328 consecutive patients with stable CAD who underwent PCI between January 2017 and December 2020. We scored the ARC-HBR criteria by assigning 1 point to each major criterion and 0.5 points to each minor criterion. Patients were stratified into low (ARC-HBR score < 1), intermediate (1 ≤ ARC-HBR score < 2), and high (ARC-HBR score ≥ 2) bleeding-risk groups. The primary outcome measure was major adverse cardiovascular events (MACE), defined as a composite of all-cause death, nonfatal myocardial infarction, and nonfatal stroke. We compared the discriminative abilities of the ARC-HBR score with the Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention (TRS2°P) and ARC-HBR score with Coronary Revascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) thrombotic risk score. The mean patient age was 70.1 ± 10.2 years (males, 76.8%). During the median follow-up period of 983 (618-1338) days, 44 patients developed MACE. Kaplan-Meier curves showed that a stepwise significant increase in the cumulative incidence of MACE as the ARC-HBR score increased (log-rank p < 0.001). In the time-dependent receiver-operating characteristic curve analysis for predicting MACE within 2 years, the area under the curve (AUC) of the ARC-HBR score was significantly higher than that of the TRS2°P (AUC: 0.825 vs. 0.725, p value for the difference = 0.023) and similar to that of CREDO-Kyoto thrombotic risk score (AUC: 0.825 vs. 0.813, p value for the difference = 0.627). Conclusions: The ARC-HBR score adequately stratified future risk of MACE in patients with stable CAD who underwent PCI. The ARC-HBR score showed a higher discriminative ability for predicting mid-term MACE than the TRS2°P.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionCoronary Artery DiseaseHemorrhageHumansMaleFemaleAgedRisk AssessmentRisk FactorsRetrospective StudiesTreatment OutcomeJapanMiddle AgedTime FactorsFollow-Up Studies

Stichwörter der Autor:innen

Academic Research Consortium for High Bleeding Risk (ARC-HBR)Major adverse cardiovascular eventPercutaneous coronary interventionStable coronary artery disease

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Kagoshima City Hospital, Kagoshima, Japan.
  • Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City, Kagoshima, 890-8520, Japan. akihiro@med.u-ryuky…
  • Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus School of Medicine, Okinawa, Japan. akihiro@med.u-ryukyu.ac.jp.
  • Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City, Kagoshima, 890-8520, Japan.

Zitieren

APA

Shimono, H., Tokushige, A., Kanda, D., Ohno, A., Arikawa, R., Chaen, H., Okui, H., Oketani, N., & Ohishi, M. (2024). Clinical impact of Academic Research Consortium for High Bleeding-Risk scores on clinical outcomes in patients with stable coronary artery disease undergoing percutaneous coronary intervention. Heart and Vessels. https://doi.org/10.1007/s00380-024-02428-z

Vancouver

Shimono H, Tokushige A, Kanda D, Ohno A, Arikawa R, Chaen H, et al. Clinical impact of Academic Research Consortium for High Bleeding-Risk scores on clinical outcomes in patients with stable coronary artery disease undergoing percutaneous coronary intervention. Heart and Vessels. 2024. doi:10.1007/s00380-024-02428-z

BibTeX
@article{Shimono2024,
  author = {Shimono, Hirokazu and Tokushige, Akihiro and Kanda, Daisuke and Ohno, Ayaka and Arikawa, Ryo and Chaen, Hideto and Okui, Hideki and Oketani, Naoya and Ohishi, Mitsuru},
  title = {Clinical impact of Academic Research Consortium for High Bleeding-Risk scores on clinical outcomes in patients with stable coronary artery disease undergoing percutaneous coronary intervention},
  journal = {Heart and Vessels},
  year = {2024},
  doi = {10.1007/s00380-024-02428-z}
}
Kostenlos starten →